EVOQ REMEDIES LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 11.91 INR | +1.97% |
|
+27.38% | -19.25% |
| 22/06 | Evoq Remedies Limited announced that it has received INR 192.1 million in funding | CI |
| 11/06 | Evoq Remedies Limited announced that it expects to receive INR 192.1 million in funding | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration
EVOQ Remedies Limited is an India-based company, which is a manufacturer and supplier of pharmaceutical products. The Company is engaged in the pharmaceutical business involving marketing, trading, and distribution of a range of pharmaceutical formulation products, such as antibiotic drugs, anti-malarial drugs, anti-allergic and cold drugs, analgesic/antipyretic and anti-inflammatory drugs, dermatology products, cerebral activator drugs, neurological drugs, gastrointestinal drugs, steroids, gynecology drugs, calcium, multivitamins, antioxidants, and injections. It offers a range of pharmaceutical formulation products, of which around 120 products are marketed by the Company under its own brand name. It also deals in the trading of active pharmaceutical ingredients (APIs). Its products include Abacavir Sulphate, Acetazolamide, Acyclovir, Adefovir Dipivoxil Allylestrenole, Alpha Beta Arteether, Alpha Lipoic Acid, Alprazolam , Amoxycillin Trihydrate, Ampicillin Trihydrate, and more.
Sector
Pharmaceuticals
Calendar
06/11/2024
- Q2 2025 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -19.25% | 1.9M | |
| +56.45% | 819B | |
| -6.50% | 351B | |
| +18.54% | 329B | |
| +9.37% | 298B | |
| +16.94% | 242B | |
| +2.09% | 225B | |
| +13.17% | 217B | |
| +8.80% | 168B | |
| -2.83% | 158B |
- Stock Market
- Equities
- 543500 Stock
- News Evoq Remedies Limited
- Evoq Remedies Bags Contract Worth INR1.4 Billion
